Literature DB >> 17254531

The role of hyperthermia in combined treatment in the management of soft tissue sarcoma.

Rolf D Issels1, Marcus Schlemmer, Lars H Lindner.   

Abstract

For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival. Systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS. This short overview summarizes the results of the combination with regional hyperthermia as a new treatment strategy to open a new therapeutic window.

Entities:  

Mesh：

Year:  2006        PMID： 17254531     DOI： 10.1007/s11912-006-0037-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  12 in total

1.  Postoperative nomogram for 12-year sarcoma-specific death.

Authors:  Michael W Kattan; Denis H Y Leung; Murray F Brennan
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

2.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

Authors:  P W Pisters; D H Leung; J Woodruff; W Shi; M F Brennan
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

3.  Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.

Authors:  E Stoeckle; J M Coindre; S Bonvalot; G Kantor; P Terrier; F Bonichon; B Nguyen Bui
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

4.  Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.

Authors:  R D Issels; S Abdel-Rahman; C Wendtner; M H Falk; V Kurze; H Sauer; U Aydemir; W Hiddemann
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

5.  Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.

Authors:  C Wendtner; S Abdel-Rahman; J Baumert; M H Falk; M Krych; M Santl; W Hiddemann; R D Issels
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

6.  Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.

Authors:  R D Issels; S W Prenninger; A Nagele; E Boehm; H Sauer; K W Jauch; H Denecke; H Berger; K Peter; W Wilmanns
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

7.  Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Authors:  William G Kraybill; Jonathon Harris; Ira J Spiro; David S Ettinger; Thomas F DeLaney; Ronald H Blum; David R Lucas; David C Harmon; G Douglas Letson; Burton Eisenberg
Journal:  J Clin Oncol       Date:  2006-02-01       Impact factor: 44.544

Review 8.  Hyperthermia in combined treatment of cancer.

Authors:  P Wust; B Hildebrandt; G Sreenivasa; B Rau; J Gellermann; H Riess; R Felix; P M Schlag
Journal:  Lancet Oncol       Date:  2002-08       Impact factor: 41.316

9.  Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.

Authors:  R D Issels; J Mittermüller; A Gerl; W Simon; A Ortmaier; C Denzlinger; H Sauer; W Wilmanns
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.

Authors:  Clemens-M Wendtner; Sultan Abdel-Rahman; Matthäus Krych; Jens Baumert; Lars H Lindner; Andrea Baur; Wolfgang Hiddemann; Rolf D Issels
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544
View more
  3 in total

1.  Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.

Authors:  Feng Lv; Yang Yu; Bin Zhang; Dong Liang; Zhao-Ming Li; Wei You
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

2.  [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].

Authors:  M Lehnhardt; A Daigeler; H H Homann; J Hauser; S Langer; L Steinsträsser; C Soimaru; A Puls; H U Steinau
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

3.  Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.

Authors:  Katsumi Abe; Toshiya Maebayashi; Takashi Shizukuishi; Masakuni Sakaguchi; Satoru Furuhashi; Motoichiro Takahashi; Yoshiaki Tanaka; Akihito Uematsu; Masahiko Sugitani
Journal:  Med Oncol       Date:  2009-10-10       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.